Skip to main content
Clinical Trials/NCT04995900
NCT04995900CompletedNot Applicable

Heart Matters: A Stepped-wedge Cluster Randomized Controlled Trial of Heart Health Education Targeting Communities at High Risk of Acute Coronary Syndrome.

Monash University1 site in 1 country2,240 target enrollmentStarted: February 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,240
Locations
1
Primary Endpoint
Ambulance use for ACS

Study Overview

Brief Summary

The aim of the study is to evaluate whether providing a targeted heart health education campaign to regions at high risk of heart attacks will improve ACS patient's symptom recognition and response.

The intervention will be will be evaluated according to a cluster randomized, stepped wedged design. The clusters are eight local government areas (LGAs) in Victoria, Australia. The main primary outcome will be assessed in consecutive patients presenting to emergency departments from the six LGAs throughout the study period with an ED diagnoses of acute coronary syndrome.

Detailed Description

Primary objectives:

To determine if targeted heart health education will:

  1. Increase ambulance use in ACS patients (main primary outcome);
  2. Decrease patient and prehospital delay times in ACS patients;
  3. Increase awareness of personal cardiovascular risk and associated factors in adult community members; and
  4. Increase cardiovascular knowledge and confidence to act to heart attack warning signs in adult community members.

Secondary objectives

  1. To determine if targeted heart health education:
  2. Reduces the incidence of out-of-hospital cardiac arrest;
  3. Improves survival in OHCA patients;
  4. Improves survival in ACS patients;
  5. Improves survival and ACS patients;
  6. Increases presentations to ED for ACS and unspecified chest pain; and
  7. Increases the rates of calls to ambulance for chest pain and non-chest pain.
  8. Increases the rate of Heart Health Checks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Masking Description

Outcomes are collected blinded to the study allocation.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult residents of the eight local government areas -

Exclusion Criteria

  • •Adults not residing in the eight local government areas.

Arms & Interventions

Intervention

Experimental

Intervention period with active Heart Matters education delivered

Intervention: Community education (Other)

Control

No Intervention

Control period with no Heart Matters education delivered.

Outcomes

Primary Outcomes

Ambulance use for ACS

Time Frame: 16 months

The proportion of ACS patients that present to ED by ambulance.

Secondary Outcomes

  • Number of correctly named heart attack risk factors(0-2 months and 6-8 months)
  • ACS patients prehospital delay times <120 minutes(16 months)
  • Median ACS patient delay time(16 months)
  • ACS patient delay time <60 minutes(16 months)
  • Awareness of heart attack signs and symptoms(0-2 months and 6-8 months)
  • Rates of Heart Health Checks(16 months)
  • ACS ED presentations via GPs(16 months)
  • Rates of ACS survival(16 months)
  • Median ACS patient prehospital delay time(16 months)
  • Awareness of own risk of heart attack(0-2 months and 6-8 months)
  • Awareness of heart attack risk factors(0-2 months and 6-8 months)
  • Confidence in knowing how to act(0-2 months and 6-8 months)
  • Ambulance use in scenarios(0-2 months and 6-8 months)
  • Rates of unspecified chest pain ED presentations(16 months)
  • Rates of OHCA(16 months)
  • Calls to ambulance for chest pain(16 months)
  • Awareness of heart attack as a leading cause of death(0-2 months and 6-8 months)
  • Number of correctly named heart attack signs and symptoms(0-2 months and 6-8 months)
  • Rates of ACS ED presentations(16 months)
  • Calls to ambulance for non- chest pain(16 months)
  • Incidence of OHCA(16 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Janet

Associate Professor

Monash University

Study Sites (1)

Loading locations...

Similar Trials